SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-19-031046
Filing Date
2019-06-14
Accepted
2019-06-14 17:24:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tv523621_424b3.htm 424B3 25922
2 GRAPHIC lg_outlook-therapeutics.jpg GRAPHIC 27892
  Complete submission text file 0001144204-19-031046.txt   65554
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B3 | Act: 33 | File No.: 333-229761 | Film No.: 19899825
SIC: 2836 Biological Products, (No Diagnostic Substances)